HER2-positive cancers are aggressive, but the good news is many can be treated with targeted therapies.
The bad news, those drugs can hurt the heart.
Now, researchers have found a way to successfully treat HER2-positive cancer and protect patients from heart failure.
Courtney Hunter shows you how in Healthy Living.
Nanci remains cancer-free but will have to stay on targeted therapies for the rest of her life.
Dr. Barac says all of the women in the SAFE-HEaRt trial, with the exception of three, were able to remain on their cancer therapies safely during the trial.